# US Bone Joint Health Ingredients Market > 米国の骨関節健康成分市場調査レポート: 種類別 (カルシウム、コラーゲン、グルコサミン、コンドロイチン、マグネシウム、ビタミン) および用途別 (栄養補助食品および栄養補助食品、食品および飲料、医薬品) - 2035 年までの予測 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.5% - **2024:** $ 4,500 Million - **2025:** $ 4,792.5 Million - **2035:** $ 9,000 Million - **Key Players:** Nestle (CH), Amway (US), Herbalife (US), BASF (DE), DuPont (US), GSK (GB), Abbott (US), Pfizer (US), Sanofi (FR) **Report ID:** MRFR/FnB/13823-HCR · **Pages:** 128 · **Author:** Snehal Singh · **Last Updated:** July 20, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-bone-joint-health-ingredients-market-15350 --- ## Market Summary ## **US Bone Joint Health Ingredients Market Overview** US Bone Joint Health Ingredients Market Size was estimated at 3.22 (USD Billion) in 2023. The US Bone Joint Health Ingredients Market Industry is expected to grow from 3.75(USD Billion) in 2024 to 8.5 (USD Billion) by 2035. The US Bone Joint Health Ingredients Market CAGR (growth rate) is expected to be around 7.723% during the forecast period (2025 - 2035). Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Key US Bone Joint Health Ingredients Market Trends Highlighted** The US Bone Joint Health Ingredients Market is experiencing several significant trends that reflect the evolving landscape of consumer health and wellness. Increasing awareness regarding the importance of maintaining bone and joint health has emerged as a key market driver. A growing aging population, notably the significant percentage of adults over 65 years, has heightened the focus on bone health, driving demand for supplements and functional foods that support joint function and mobility. Additionally, the rise in lifestyle-related ailments and the prevalence of conditions such as arthritis have prompted consumers to seek preventive health solutions, further boosting interest in bone joint health ingredients.Opportunities within this market present themselves through the exploration of emerging natural ingredients and innovations in formulations. Consumers are increasingly opting for plant-based options, signaling a shift towards more natural, clean-label products. This trend opens the door for businesses to innovate with ingredients like curcumin, glucosamine sourced from non-shellfish sources, or even collagen from alternative sources to cater to specific dietary preferences. Recent developments also indicate a growing emphasis on scientifically-backed products, with consumers demanding transparency regarding ingredient efficacy and sourcing.Collaborations with research institutions for clinical studies may present businesses with opportunities to validate their products, enhancing trust and credibility among consumers. Digital platforms are becoming essential for outreach, enabling companies to educate consumers on the benefits of these ingredients effectively. Overall, the US Bone Joint Health Ingredients Market continues to evolve through these trends and drivers, highlighting a robust landscape for both existing and new players in the industry. **US Bone Joint Health Ingredients Market Drivers** **Aging Population in the United States** The aging population in the United States is a crucial driver of the US Bone Joint Health Ingredients Market Industry. The U.S. Census Bureau reported that by 2030, all baby boomers will be at least 65 years old, increasing the senior population to over 78 million. This demographic shift presents ample opportunities for growth in bone and joint health products, as older adults are more susceptible to osteoarthritis and osteoporosis, leading to a rising demand for dietary supplements and functional foods containing bone joint health ingredients.Moreover, the National Institute of Arthritis and Musculoskeletal and Skin Diseases indicates that more than 50 million adults have doctor-diagnosed arthritis, which results in significant healthcare expenses and fuels demand for preventive and therapeutic solutions. With a demographic trend that shows an escalation in age-related ailments and the potential for market expansion, the US Bone Joint Health Ingredients Market Industry is well-positioned for future growth. **Increased Awareness of Bone and Joint Health** In recent years, there has been a significant increase in awareness of bone and joint health among the American population. According to the Centers for Disease Control and Prevention (CDC), education initiatives highlighting the significance of maintaining healthy bones and joints have reached millions, contributing to a surge in preventive healthcare measures. Surveys have indicated that approximately 70% of adults are now aware of the importance of proper nutrition and exercise in maintaining bone health.This growing consciousness is leading to greater consumer investment in supplements containing vitamins, minerals, and other ingredients that promote bone and joint health, thus driving the US Bone Joint Health Ingredients Market Industry. **Rising Healthcare Costs and Preventive Health Trends** Rising healthcare costs in the United States are pushing consumers toward preventive health measures, including dietary supplements for bone and joint health. According to the National Health Expenditure Accounts, healthcare spending is projected to grow at an average rate of 5.4% per year and reach nearly 20% of the Gross Domestic Product (GDP) by 2028. In response, individuals are increasingly prioritizing preventive care to mitigate potential future medical expenses.The National Osteoporosis Foundation also notes that the total direct costs for osteoporosis-related fractures was estimated at $19 billion in 2016, emphasizing the financial burden of bone health issues. This trend encourages consumers to explore dietary solutions, thus fostering growth in the US Bone Joint Health Ingredients Market Industry. **US Bone Joint Health Ingredients Market Segment Insights** **Bone Joint Health Ingredients Market Type Insights** The US Bone Joint Health Ingredients Market is characterized by a diverse array of types, prominently featuring Calcium, Collagen, Glucosamine, Chondroitin, Magnesium, and Vitamins, each of which plays a pivotal role in maintaining skeletal health. Calcium is often regarded as a cornerstone for bone density and strength, reflecting its significance in diets, especially for aging populations. Collagen, a protein that provides structure to bones, cartilage, and connective tissues, is increasingly recognized for its ability to support joint health and reduce symptoms of wear and tear, making it a popular choice among consumers focused on joint mobility.Glucosamine and Chondroitin are well-known supplements used for their potential impact on joint pain relief and cartilage repair, highlighting consumer awareness and demand for products that aid in arthritis management. Magnesium is critical as it assists in bone mineralization and plays a key role in the maintenance of muscle function, which is essential for overall mobility. Additionally, a variety of Vitamins, particularly Vitamin D, are essential for calcium absorption and bone health, emphasizing the synergistic relationship between these nutrients.The segmentation of the US Bone Joint Health Ingredients Market allows for targeted product development and marketing strategies, as consumers become increasingly knowledgeable about the benefits of these ingredients. As the population ages, the demand for these types is anticipated to grow, driven by the increasing prevalence of bone-related issues and a greater focus on preventive health measures. Overall, this market segment is crucial not only for its unique contributions to bone and joint health but also for its reflection of broader health trends focused on wellness and preventive care. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Bone Joint Health Ingredients Market Application Insights** The Application segment of the US Bone Joint Health Ingredients Market plays a significant role in addressing the rising demand for health-related products among consumers. With an increasing awareness of maintaining bone and joint health, Nutraceuticals and dietary supplements are gaining traction, as they provide essential nutrients that support overall skeletal wellness, often becoming a preferred choice for preventive health measures. In addition, the Food and Beverages sector is crucial as it incorporates functional ingredients that cater to health-conscious consumers, thus fostering a rising trend towards incorporating bone health-promoting components into everyday diets.Pharmaceuticals also hold a noteworthy position in this market, driven by a growing population that requires medical interventions for bone and joint disorders, indicating an increasing reliance on medication to manage health challenges. The diverse applications in the US Bone Joint Health Ingredients Market highlight the multifaceted approach towards enhancing bone and joint health, supported by consumer trends that favor holistic health solutions. As lifestyle diseases become more prevalent, these segments are set to capture significant market share, driven by innovative product development and a surge in preventive healthcare initiatives. **US Bone Joint Health Ingredients Market Key Players and Competitive Insights** The competitive landscape of the US Bone Joint Health Ingredients Market is characterized by a diverse array of key players, each vying for market share while innovating to meet the growing demand for effective bone and joint health solutions. This market has expanded due to rising health awareness, an aging population, and increasing incidences of bone-related ailments. Various companies are engaged in research and development activities to enhance product offerings and to penetrate emerging trends such as natural and plant-based ingredients. As a result, competition has intensified, with players focusing on marketing strategies, partnerships, and innovative product formulations to gain an edge in this lucrative segment. Regulatory considerations also play a crucial role, driving companies to align their product ingredients with safety standards while also exploring opportunities in different distribution channels to better reach end consumers.Merial has established a solid presence in the US Bone Joint Health Ingredients Market, leveraging its deep expertise in animal health products to tap into the growing demand for supplements that support joint performance and mobility. The company's primary strengths lie in its extensive research capabilities and a strong focus on innovation, which have enabled it to develop specialized formulations that cater to diverse consumer needs. With a commitment to quality and safety, Merial emphasizes the efficacy of its products, often backed by clinical trials or scientific studies. The company has successfully positioned itself as a reliable player in the market, and its focus on customer engagement further enhances brand loyalty in a competitive landscape.Celgene, a prominent entity in the US Bone Joint Health Ingredients Market, is known for its innovative approaches and comprehensive product lines that include pharmaceuticals aimed at supporting bone health. Key products typically address issues related to inflammation and joint mobility, making them favorable among healthcare professionals and patients alike. Celgene has leveraged partnerships and strategic mergers to bolster its market presence, allowing for greater distribution channels and increased access to a broader consumer base. The company’s strengths lie in its commitment to cutting-edge research, which drives the development of next-generation therapies. This proactive stance has not only solidified its market position but has also enhanced its reputation for quality and efficacy. Through continuous exploration of collaboration opportunities and acquisition of complementary businesses, Celgene is well-poised for sustained growth. **Key Companies in the US Bone Joint Health Ingredients Market Include** - Merial - Celgene - Novartis - AstraZeneca - Merck - [GlaxoSmithKline](https://www.gsk.com/en-gb/products/) - Eli Lilly - BristolMyers Squibb - Regeneron Pharmaceuticals - Pfizer - Amgen - AbbVie - Roche - Sanofi - Johnson and Johnson **US Bone Joint Health Ingredients Market Industry Developments** In recent developments within the US Bone Joint Health Ingredients Market, companies like Merial, Celgene, Novartis, and AstraZeneca have been focusing on advanced research pertaining to novel treatments and ingredients promoting bone and joint health. Merck has initiated trials for new formulations that leverage innovative compounds aimed at improving joint functioning. In October 2023, Pfizer announced an intention to expand its product line related to osteoarthritis, hinting at increased market competition. Significant growth has been observed, particularly with Amgen and AbbVie looking to enhance their portfolios through strategic partnerships aimed at R&D for joint health solutions. Over the past two years, major events include the merger between Bristol-Myers Squibb and Celgene in April 2019, which enhanced their capabilities in biologic therapies targeting bone and joint disorders. Sanofi has also been in discussions regarding potential acquisitions to fortify its position in the joint health segment. As of mid-2023, the market valuation has seen an upward shift, driven by increased consumer awareness and a rising geriatric population, prompting higher demand for effective bone health interventions. **US Bone Joint Health Ingredients Market Segmentation Insights** - **Bone Joint Health Ingredients Market Type****Outlook** - Calcium - Collagen - Glucosamine - Chondroitin - Magnesium - Vitamins - **Bone Joint Health Ingredients Market Application****Outlook** - Nutraceuticals & dietary supplements - Food and Beverages - Pharmaceuticals ## Market Drivers ### Rising Healthcare Costs and Preventive Care The rising costs associated with healthcare in the United States are prompting consumers to seek preventive care solutions, which is beneficial for the bone joint-health-ingredients market. As healthcare expenses continue to escalate, individuals are increasingly inclined to invest in dietary supplements and functional foods that promote joint health. The National Health Expenditure Accounts indicate that healthcare spending in the U.S. is projected to reach $6 trillion by 2027. This financial pressure encourages consumers to prioritize preventive measures, such as incorporating bone joint-health-ingredients into their diets, to avoid costly medical treatments. As a result, the market is witnessing a surge in demand for effective and affordable joint health solutions. ### Regulatory Support and Research Advancements Regulatory support and advancements in research related to bone joint-health-ingredients are contributing positively to the market. The U.S. Food and Drug Administration (FDA) has established guidelines that facilitate the development and marketing of dietary supplements, including those targeting joint health. Furthermore, ongoing research into the efficacy of various ingredients, such as glucosamine and chondroitin, is providing a scientific basis for their use in joint health products. This research is likely to enhance consumer confidence and drive demand within the bone joint-health-ingredients market. As more studies validate the benefits of these ingredients, manufacturers are expected to invest in product development, leading to a broader range of offerings in the market. ### Growing Interest in Functional Foods and Supplements The increasing consumer interest in functional foods and dietary supplements is a notable driver for the bone joint-health-ingredients market. Consumers are becoming more health-conscious and are actively seeking products that offer additional health benefits beyond basic nutrition. According to a survey by the Council for Responsible Nutrition, approximately 77% of U.S. adults take dietary supplements, with joint health being a key focus area. This trend is likely to propel the market as manufacturers develop innovative bone joint-health-ingredients that cater to the demand for functional products. The integration of these ingredients into everyday foods and beverages is expected to further enhance market growth, as consumers look for convenient ways to support their joint health. ### Increased Sports Participation and Active Lifestyles The growing trend of sports participation and active lifestyles among various age groups in the United States is significantly influencing the bone joint-health-ingredients market. As more individuals engage in physical activities, the risk of joint injuries and wear-and-tear increases, leading to a heightened demand for products that support joint health. The Sports & Fitness Industry Association reports that over 60% of Americans participate in some form of sports or fitness activity. This trend is likely to drive the market as athletes and fitness enthusiasts seek supplements and ingredients that enhance joint function and recovery. Consequently, manufacturers are innovating to create specialized bone joint-health-ingredients tailored to the needs of active individuals. ### Aging Population and Increased Joint Health Awareness The aging population in the United States is a primary driver for the bone joint-health-ingredients market. As individuals age, they often experience a decline in joint health, leading to increased awareness and demand for products that support bone and joint health. According to the U.S. Census Bureau, by 2030, all baby boomers will be over 65 years old, which is expected to significantly increase the prevalence of joint-related issues. This demographic shift is likely to drive the market as older adults seek preventive measures and treatments to maintain mobility and quality of life. Consequently, manufacturers are focusing on developing innovative bone joint-health-ingredients that cater to this growing segment, thereby expanding their market presence. ## Future Outlook The [Bone Joint Health Ingredients Market](https://www.marketresearchfuture.com/reports/bone-joint-health-ingredients-market-4679) is projected to grow at a 6.5% CAGR from 2025 to 2035, driven by increasing consumer awareness and demand for preventive health solutions. **New opportunities:** - Development of personalized joint health supplements - Expansion into e-commerce platforms for direct sales - Partnerships with fitness and wellness centers for product integration By 2035, the market is expected to achieve robust growth, reflecting evolving consumer health priorities. ## Segment Insights ### By Type: Calcium (Largest) vs. Collagen (Fastest-Growing) In the US bone joint-health-ingredients market, the segment values exhibit a diverse landscape, with Calcium holding the largest share due to its well-established benefits for bone health and widespread consumer recognition. Following closely are Glucosamine and Chondroitin, which together capture a significant portion of market preferences thanks to their reputed efficacy in joint care. Magnesium and Vitamins make a smaller, yet still relevant, impact as supplementary ingredients that enhance overall joint and bone health. Collagen emerges as the fastest-growing ingredient in this segment, driven by increasing consumer awareness and demand for natural products that support joint elasticity and overall wellness. Factors fueling this growth include rising interest in preventive health measures and the growing popularity of collagen supplements among older adults seeking to maintain mobility and joint health as they age. As research continues to highlight its benefits, the segment's dynamism is expected to attract more investment and innovation in the coming years. Calcium: Dominant vs. Collagen: Emerging Calcium remains dominant in the US bone joint-health-ingredients market due to its long-standing reputation as a critical nutrient for bone density and structural integrity. Its accessibility in various forms, such as powders, tablets, and fortified foods, makes it a staple among consumers. However, Collagen is rapidly becoming an emerging ingredient, thanks to its promising benefits not only for joint health but also for skin and hair. This multifaceted appeal has led to robust marketing strategies that resonate with health-conscious consumers. The versatility of Collagen in different formulations, along with rising trends in skincare and beauty from within, positions it as a strong competitor to Calcium, especially among younger demographics aiming for holistic health solutions. ### By Application: Nutraceuticals & Dietary Supplements (Largest) vs. Pharmaceuticals (Fastest-Growing) The application segment in the US bone joint-health-ingredients market is primarily dominated by nutraceuticals and dietary supplements, which capture the largest market share. These products play a crucial role in the daily maintenance and improvement of joint health, driving widespread consumer adoption. Pharmaceuticals hold a significant presence but are rapidly gaining traction as an attractive alternative due to their targeted efficacy and prescribed use against specific conditions. As consumer awareness and preferences evolve, these segments show distinct dynamics within the market landscape. Growth trends within the application segment highlight the increasing demand for natural and preventive health solutions, particularly in nutraceuticals and dietary supplements, which reflect the shift towards self-care. Pharmaceuticals are emerging as the fastest-growing sector, propelled by innovations that appeal to aging populations and those seeking enhanced quality of life. Factors such as rising health consciousness and an aging demographic create a robust environment for both established and emerging products. Nutraceuticals & Dietary Supplements (Dominant) vs. Pharmaceuticals (Emerging) Nutraceuticals and dietary supplements stand out as dominant forces in the application segment, characterized by a diverse range of formulations aimed at promoting joint health. Their popularity among consumers is bolstered by the growing trend toward preventive healthcare and wellness. Conversely, the pharmaceutical segment is marked by its emerging status, driven by novel therapeutic approaches and targeted interventions for joint-related ailments. The rising adoption of prescription formulations and the ongoing development of effective solutions tailored to complex conditions reflect the dynamic competition between these segments. With each showing unique characteristics and market propositions, the interplay between nutraceuticals and pharmaceuticals continues to shape consumer choices in the US bone joint-health-ingredients market. ## Competitive Benchmarking The bone joint-health-ingredients market is currently characterized by a dynamic competitive landscape, driven by increasing consumer awareness regarding joint health and the rising prevalence of musculoskeletal disorders. Key players such as Nestle (CH), Amway (US), and Herbalife (US) are strategically positioning themselves through innovation and product diversification. Nestle (CH) has focused on enhancing its portfolio with scientifically-backed ingredients, while Amway (US) emphasizes direct-to-consumer sales channels to strengthen customer relationships. Herbalife (US) is leveraging its global distribution network to expand its reach, indicating a collective strategy among these companies to enhance market penetration and consumer engagement.In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. The market structure appears moderately fragmented, with several players competing for market share. However, the influence of major companies is significant, as they set trends in product development and marketing strategies. This competitive structure fosters an environment where innovation and responsiveness to consumer needs are paramount. In October Nestle (CH) announced a partnership with a leading biotechnology firm to develop a new line of joint health supplements utilizing advanced bioengineering techniques. This strategic move is likely to enhance Nestle's product efficacy and appeal, positioning the company as a frontrunner in the innovation of joint health solutions. Such collaborations may also signal a shift towards more personalized nutrition, catering to specific consumer needs. In September Amway (US) launched a new digital platform aimed at enhancing customer engagement through personalized health assessments and tailored product recommendations. This initiative underscores Amway's commitment to digital transformation, potentially increasing customer loyalty and driving sales growth. By integrating technology into its business model, Amway is likely to create a more interactive consumer experience, which could be a critical differentiator in the competitive landscape. In August Herbalife (US) expanded its product line to include plant-based joint health supplements, responding to the growing demand for vegan and sustainable options. This strategic expansion not only aligns with current consumer trends but also positions Herbalife to capture a broader market segment. The emphasis on sustainability may resonate well with environmentally conscious consumers, enhancing brand loyalty and market share. As of November the competitive trends in the bone joint-health-ingredients market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances are shaping the landscape, enabling companies to pool resources and expertise for enhanced innovation. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition towards innovation, technology integration, and supply chain reliability. Companies that can effectively leverage these trends are likely to secure a competitive edge in this rapidly evolving market. ## Recent News & Developments In recent developments within the US Bone Joint Health Ingredients Market, companies like Merial, Celgene, Novartis, and AstraZeneca have been focusing on advanced research pertaining to novel treatments and ingredients promoting bone and joint health. Merck has initiated trials for new formulations that leverage innovative compounds aimed at improving joint functioning. In October 2023, Pfizer announced an intention to expand its product line related to osteoarthritis, hinting at increased market competition. Significant growth has been observed, particularly with Amgen and AbbVie looking to enhance their portfolios through strategic partnerships aimed at R&D for joint health solutions. Over the past two years, major events include the merger between Bristol-Myers Squibb and Celgene in April 2019, which enhanced their capabilities in biologic therapies targeting bone and joint disorders. Sanofi has also been in discussions regarding potential acquisitions to fortify its position in the joint health segment. As of mid-2023, the market valuation has seen an upward shift, driven by increased consumer awareness and a rising geriatric population, prompting higher demand for effective bone health interventions. ## Report Scope | MARKET SIZE 2024 | 4500.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 4792.5(USD Million) | | MARKET SIZE 2035 | 9000.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.5% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Nestle (CH), Amway (US), Herbalife (US), BASF (DE), DuPont (US), GSK (GB), Abbott (US), Pfizer (US), Sanofi (FR) | | Segments Covered | Type, Application | | Key Market Opportunities | Growing consumer demand for natural and plant-based ingredients in the bone joint-health-ingredients market. | | Key Market Dynamics | Rising consumer demand for natural ingredients drives innovation in the bone joint-health-ingredients market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US bone joint-health-ingredients market?** A: The market valuation was $4500.0 Million in 2024. **Q: What is the projected market size for the US bone joint-health-ingredients market by 2035?** A: The market is projected to reach $9000.0 Million by 2035. **Q: What is the expected CAGR for the US bone joint-health-ingredients market during the forecast period 2025 - 2035?** A: The expected CAGR is 6.5% during the forecast period. **Q: Which segment had the highest valuation in the US bone joint-health-ingredients market in 2024?** A: Glucosamine had the highest valuation at $1350.0 Million in 2024. **Q: What are the key applications of bone joint-health-ingredients in the US market?** A: Key applications include nutraceuticals & dietary supplements, food and beverages, and pharmaceuticals. **Q: How much is the nutraceuticals & dietary supplements segment valued at in 2024?** A: The nutraceuticals & dietary supplements segment was valued at $1800.0 Million in 2024. **Q: Which companies are considered key players in the US bone joint-health-ingredients market?** A: Key players include Nestle, Amway, Herbalife, BASF, DuPont, GSK, Abbott, Pfizer, and Sanofi. **Q: What is the valuation range for the collagen segment in the US bone joint-health-ingredients market?** A: The valuation range for the collagen segment is $900.0 Million to $1800.0 Million. **Q: What is the projected growth for the food and beverages segment by 2035?** A: The food and beverages segment is projected to grow to $2700.0 Million by 2035. **Q: How does the valuation of the chondroitin segment compare to that of magnesium in 2024?** A: In 2024, the chondroitin segment was valued at $675.0 Million, while magnesium was also valued at $450.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-bone-joint-health-ingredients-market-15350*